VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USDVANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USDVANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD

VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪5.09 M‬USD
Fund flows (1Y)
‪−1.03 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
0.4%
Shares outstanding
‪240.00 K‬
Expense ratio
0.55%

About VANECK UCITS ETFS PLC BIONIC ENGINEERING UCITS ETF A USD


Issuer
Van Eck Associates Corp.
Brand
VanEck
Home page
Inception date
Dec 2, 2022
Structure
Irish VCIC
Index tracked
MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net
Replication method
Physical
Management style
Passive
ISIN
IE0005TF96I9
Functions as an open-end investment fund

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of January 17, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.69%
Health Technology95.37%
Distribution Services2.52%
Electronic Technology1.80%
Bonds, Cash & Other0.31%
Cash0.31%
Stock breakdown by region
4%78%15%1%
North America78.40%
Europe15.49%
Oceania4.54%
Asia1.57%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows